Skip to main content

Table 2 Comparison of T790M mutation, as detected by ddPCR and ARMS

From: Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study

ARMS ddPCR Total
T790M+ T790M−
T790M+ 87 8 95
T790M− 58 154 212
Total 145 162 307
  1. ARMS amplification refractory mutation system, ddPCR droplet digital PCR